| Autor: |
Falkson G, Van Dyk JJ, Stapelberg R, Falkson HC |
| Jazyk: |
angličtina |
| Zdroj: |
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 1982; Vol. 9 (2), pp. 81-4. |
| DOI: |
10.1007/BF00265383 |
| Abstrakt: |
Thirty-two patients with advanced cancer were treated in a phase I-II trial with ifosfamide plus mesnum. At doses up to 300 mg ifosfamide/kg the administration of mesnum prevented most of the expected kidney and bladder toxicity. With this high dose range hemopoietic dose-limiting. Only one of twelve evaluable patients with breast cancer showed definite therapeutic benefit. Complete remission or partial remission was seen in three patients with non-Hodgkin lymphoma and one patient with Hodgkin's disease. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
Full text from SpringerLink